ChemicalBook Optimization Suppliers |
|
| Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer 製品概要 |
化学名: | | 英語化学名: | Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer | 别名: | Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer;Labetuzumab;Research Grade Labetuzumab(DHC21001);IMMU-14|||hMN-14|||IMMU-100;Research Grade Labetuzumab;Labetuzumab (anti-CEACAM5) | CAS番号: | 219649-07-7 | 分子式: | | 分子量: | 0 | EINECS: | | カテゴリ情報: | | Mol File: | Mol File | ![Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer]() |
| Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer 物理性質 |
外見 | Liquid | 色 | Colorless to light yellow |
| Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer Usage And Synthesis |
使用 | Treatment of colorectal cancer (humanized monoclonal antibody hMN-14 targeting CEA-
positive cancers). | brand name | CEA-CIDE (Immunomedics). | in vivo | Labetuzumab (0.5 mg/rat; i.v.; single) inhibits tumor growth in vivo[1]. Animal Model: | Female nu/nu mice (6 to 8-week-old; inject TT cells)[1]. | Dosage: | 0.5 mg/rat | Administration: | Intravenous injection; single (1 day post-tumor cell injection) | Result: | Significantly delaied growth of tumor, and led to 64%-70% inhibition of tumor size between days 32 and 60. |
|
|